Antara News·Indonesia·Saturday, November 14, 2026 at 10:29 AM UTC

BPOM, EDQM team up to boost Indonesian drug quality, competitiveness

Translate

Mecca, Kenzu

Jakarta (ANTARA) - Indonesia's Food and Drug Monitoring Agency (BPOM) and the European Directorate for the Quality of Medicines & HealthCare (EDQM) established collaboration to develop drug quality standards and strengthen testing laboratory capacity to bolster drug oversight.

"For Indonesia, this cooperation is expected to provide long-term benefits, both in strengthening public health protection through increasingly reliable drug quality oversight and supporting the national pharmaceutical industry’s readiness to meet international quality standards," BPOM Head Taruna Ikrar said here on Friday (Nov 13).

Ikrar assessed that aligned standards could also improve the competitiveness of Indonesian pharmaceutical products in the global market.

"We want this cooperation to produce real steps, not just agreements on paper. The hope is that Indonesia can contribute more actively to developing world drug standards while benefiting the progress of the national pharmaceutical industry," he added.

Ikrar explained the five-year strategic cooperation focuses on strengthening quality standards for drugs and drug substances, supporting development of the Indonesian Pharmacopoeia, exchanging technical information, as well as improving access to international testing knowledge and standards.

The memorandum of understanding (MoU) was signed through a desk-to-desk signing mechanism. Ikrar signed the document in Jakarta on October 1, 2026, and EDQM Director Petra Doerr signed it in Strasbourg, France, on October 20, 2026.

The BPOM will also draft a plan of action with the EDQM to turn the agreement into more concrete technical activities, focusing on drug quality standards, testing method development, laboratory competence, and Indonesia’s possible participation in international standardization programs.

The collaboration also complements Indonesia’s ongoing efforts to strengthen drug oversight, including after BPOM was recognized as a World Health Organization (WHO)-Listed Authority for vaccines.

Through international cooperation and scientific advances, BPOM is committed to improving oversight capacity and ensuring the public gets safe, effective, and quality drugs.

View the original on Antara News →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.